Skip to main content
All lobbying filings

EISAI INC.

EISAI INC. filed a Q2 report for EISAI INC. on July 20, 2026.

Lobbying for EISAI INC.

All filings by EISAI INC. · Everything EISAI INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Expenses
$790,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New Jersey

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6
Trade (domestic/foreign)

Supply chain manufacturing and tariffs, including: the Section 232 and Section 301 tariff investigations related to branded pharmaceuticals.

Copyright/Patent/Trademark

Pharmaceutical Intellectual Property (IP), including: S. 2658, Medication Affordability and Patent Integrity Act.

Manufacturing

Pharmaceutical manufacturing.

Health Issues

Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; Pharmacy Benefit Manager (PBM) reform, 340B Drug Discount Program.

Medicare/Medicaid

General Medicare and Medicaid including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; Center for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act

Taxation/Internal Revenue Code

Tax reform, including: H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

 Bills named in this filing 7
  • S. 2658
    Medication Affordability and Patent Integrity Act
  • H.R. 6130
    ASAP Act
  • S. 3267
    ASAP Act
  • H.R. 4752
    Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023
  • S. 2379
    CHANGE Act of 2023
  • H.R. 3747
    Accelerating Access to Dementia and Alzheimer’s Provider Training Act
  • H.R. 1
    One Big Beautiful Bill Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem